Sanjit S Jolly1, John A Cairns2, Salim Yusuf3, Michael J Rokoss3, Peggy Gao3, Brandi Meeks3, Sasko Kedev4, Goran Stankovic5, Raul Moreno6, Anthony Gershlick7, Saqib Chowdhary8, Shahar Lavi9, Kari Niemela10, Ivo Bernat11, Warren J Cantor12, Asim N Cheema13, Philippe Gabriel Steg14, Robert C Welsh15, Tej Sheth3, Olivier F Bertrand16, Alvaro Avezum17, Ravinay Bhindi18, Madhu K Natarajan3, David Horak19, Raymond C M Leung20, Saleem Kassam21, Sunil V Rao22, Magdi El-Omar23, Shamir R Mehta3, James L Velianou3, Samir Pancholy24, Vladimír Džavík25. 1. McMaster University and the Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada. Electronic address: sanjit.jolly@phri.ca. 2. University of British Columbia, Vancouver, BC, Canada. 3. McMaster University and the Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada. 4. University Clinic of Cardiology, Sts. Cyril and Methodius University, Skopje, Macedonia. 5. Clinical Center of Serbia and Department of Cardiology, Medical Faculty, University of Belgrade, Belgrade, Serbia. 6. University Hospital La Paz, Madrid, Spain. 7. Department of Cardiovascular Sciences, University of Leicester and NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK. 8. University Hospitals South Manchester, Manchester Academic Health Science Centre, Manchester, UK. 9. London Health Sciences Centre, Department of Medicine, London, ON, Canada. 10. Heart Center, Tampere University Hospital, Tampere, Finland. 11. University Hospital and Faculty of Medicine Pilsen, Pilsen, Czech Republic. 12. Southlake Regional Health Centre, Newmarket, ON, Canada. 13. St Michael's Hospital, Toronto, ON, Canada. 14. Université Paris-Diderot, Sorbonne Paris-Cité, INSERM Unité 1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France. 15. Mazankowski Alberta Heart Institute, Department of Medicine, Edmonton, AB, Canada. 16. Quebec Heart-Lung Institute, Laval University, Quebec, QC, Canada. 17. Dante Pazzanese Institute of Cardiology, University of Santo Amaro, Sao Paulo, Brazil. 18. Royal North Shore Hospital, Sydney, Australia. 19. Krajská Nemocnice Liberec, Liberec, Czech Republic. 20. CK Hui Heart Centre, Edmonton, AB, Canada. 21. Rouge Valley Health System, Toronto, ON, Canada. 22. Duke Clinical Research Institute, Durham, NC, USA. 23. Central Manchester Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. 24. Northeast Clinical Trials Group, Scranton, PA, USA. 25. Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.
Abstract
BACKGROUND: Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a 1-year follow-up of the largest randomised trial of thrombus aspiration, we aimed to clarify the longer-term benefits, to help guide clinical practice. METHODS: The trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in Patients with STEMI (TOTAL) was a prospective, randomised, investigator-initiated trial of routine manual thrombectomy versus percutaneous coronary intervention (PCI) alone in 10,732 patients with STEMI. Eligible adult patients (aged ≥18 years) from 87 hospitals in 20 countries were enrolled and randomly assigned (1:1) within 12 h of symptom onset to receive routine manual thrombectomy with PCI or PCI alone. Permuted block randomisation (with variable block size) was done by a 24 h computerised central system, and was stratified by centre. Participants and investigators were not masked to treatment assignment. The trial did not show a difference at 180 days in the primary outcome of cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure. However, the results showed improvements in the surrogate outcomes of ST segment resolution and distal embolisation, but whether or not this finding would translate into a longer term benefit remained unclear. In this longer-term follow-up of the TOTAL study, we report the results on the primary outcome (cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure) and secondary outcomes at 1 year. Analyses of the primary outcome were by modified intention to treat and only included patients who underwent index PCI. This trial is registered with ClinicalTrials.gov, number NCT01149044. FINDINGS:Between Aug 5, 2010, and July 25, 2014, 10,732 eligible patients were enrolled and randomly assigned to thrombectomy followed by PCI (n=5372) or to PCI alone (n=5360). After exclusions of patients who did not undergo PCI in each group (337 in the PCI and thrombectomy group and 331 in the PCI alone group), the final study population comprised 10,064 patients (5035 thrombectomy and 5029 PCI alone). The primary outcome at 1 year occurred in 395 (8%) of 5035 patients in the thrombectomy group compared with 394 (8%) of 5029 in the PCI alone group (hazard ratio [HR] 1·00 [95% CI 0·87-1·15], p=0·99). Cardiovascular death within 1 year occurred in 179 (4%) of the thrombectomy group and in 192 (4%) of 5029 in the PCI alone group (HR 0·93 [95% CI 0·76-1·14], p=0·48). The key safety outcome, stroke within 1 year, occurred in 60 patients (1·2%) in the thrombectomy group compared with 36 (0·7%) in the PCI alone group (HR 1·66 [95% CI 1·10-2·51], p=0·015). INTERPRETATION: Routine thrombus aspiration during PCI for STEMI did not reduce longer-term clinical outcomes and might be associated with an increase in stroke. As a result, thrombus aspiration can no longer be recommended as a routine strategy in STEMI. FUNDING: Canadian Institutes of Health Research, Canadian Network and Centre for Trials Internationally, and Medtronic Inc.
RCT Entities:
BACKGROUND: Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a 1-year follow-up of the largest randomised trial of thrombus aspiration, we aimed to clarify the longer-term benefits, to help guide clinical practice. METHODS: The trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in Patients with STEMI (TOTAL) was a prospective, randomised, investigator-initiated trial of routine manual thrombectomy versus percutaneous coronary intervention (PCI) alone in 10,732 patients with STEMI. Eligible adult patients (aged ≥18 years) from 87 hospitals in 20 countries were enrolled and randomly assigned (1:1) within 12 h of symptom onset to receive routine manual thrombectomy with PCI or PCI alone. Permuted block randomisation (with variable block size) was done by a 24 h computerised central system, and was stratified by centre. Participants and investigators were not masked to treatment assignment. The trial did not show a difference at 180 days in the primary outcome of cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure. However, the results showed improvements in the surrogate outcomes of ST segment resolution and distal embolisation, but whether or not this finding would translate into a longer term benefit remained unclear. In this longer-term follow-up of the TOTAL study, we report the results on the primary outcome (cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure) and secondary outcomes at 1 year. Analyses of the primary outcome were by modified intention to treat and only included patients who underwent index PCI. This trial is registered with ClinicalTrials.gov, number NCT01149044. FINDINGS: Between Aug 5, 2010, and July 25, 2014, 10,732 eligible patients were enrolled and randomly assigned to thrombectomy followed by PCI (n=5372) or to PCI alone (n=5360). After exclusions of patients who did not undergo PCI in each group (337 in the PCI and thrombectomy group and 331 in the PCI alone group), the final study population comprised 10,064 patients (5035 thrombectomy and 5029 PCI alone). The primary outcome at 1 year occurred in 395 (8%) of 5035 patients in the thrombectomy group compared with 394 (8%) of 5029 in the PCI alone group (hazard ratio [HR] 1·00 [95% CI 0·87-1·15], p=0·99). Cardiovascular death within 1 year occurred in 179 (4%) of the thrombectomy group and in 192 (4%) of 5029 in the PCI alone group (HR 0·93 [95% CI 0·76-1·14], p=0·48). The key safety outcome, stroke within 1 year, occurred in 60 patients (1·2%) in the thrombectomy group compared with 36 (0·7%) in the PCI alone group (HR 1·66 [95% CI 1·10-2·51], p=0·015). INTERPRETATION: Routine thrombus aspiration during PCI for STEMI did not reduce longer-term clinical outcomes and might be associated with an increase in stroke. As a result, thrombus aspiration can no longer be recommended as a routine strategy in STEMI. FUNDING: Canadian Institutes of Health Research, Canadian Network and Centre for Trials Internationally, and Medtronic Inc.
Authors: Ravinay Bhindi; Olli A Kajander; Sanjit S Jolly; Saleem Kassam; Shahar Lavi; Kari Niemelä; Anthony Fung; Asim N Cheema; Brandi Meeks; Dimitrios Alexopoulos; Viktor Kočka; Warren J Cantor; Timo P Kaivosoja; Olga Shestakovska; Peggy Gao; Goran Stankovic; Vladimír Džavík; Tej Sheth Journal: Eur Heart J Date: 2015-05-20 Impact factor: 29.983
Authors: Gregg W Stone; Michael A Peterson; Alexandra J Lansky; George Dangas; Roxana Mehran; Martin B Leon Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: L De Luca; G Sardella; C J Davidson; G De Persio; M Beraldi; T Tommasone; M Mancone; B L Nguyen; L Agati; M Gheorghiade; F Fedele Journal: Heart Date: 2005-10-26 Impact factor: 5.994
Authors: Bo Lagerqvist; Ole Fröbert; Göran K Olivecrona; Thórarinn Gudnason; Michael Maeng; Patrik Alström; Jonas Andersson; Fredrik Calais; Jörg Carlsson; Olov Collste; Matthias Götberg; Peter Hårdhammar; Dan Ioanes; Anders Kallryd; Rickard Linder; Anders Lundin; Jacob Odenstedt; Elmir Omerovic; Verner Puskar; Tim Tödt; Eva Zelleroth; Ollie Östlund; Stefan K James Journal: N Engl J Med Date: 2014-09-01 Impact factor: 91.245
Authors: Yoshinobu Onuma; Leif Thuesen; Robert-Jan van Geuns; Martin van der Ent; Steffen Desch; Jean Fajadet; Evald Christiansen; Peter Smits; Niels Ramsing Holm; Evelyn Regar; Nicolas van Mieghem; Vladimir Borovicanin; Dragica Paunovic; Kazuhisa Senshu; Gerrit-Anne van Es; Takashi Muramatsu; Il-Soo Lee; Gerhard Schuler; Felix Zijlstra; Hector M Garcia-Garcia; Patrick W Serruys Journal: Eur Heart J Date: 2013-02-08 Impact factor: 29.983
Authors: Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong Journal: Circulation Date: 2008-09-08 Impact factor: 29.690
Authors: Eric A Secemsky; Enrico G Ferro; Sunil V Rao; Ajay Kirtane; Hector Tamez; Pearl Zakroysky; Daniel Wojdyla; Steven M Bradley; David J Cohen; Robert W Yeh Journal: JAMA Cardiol Date: 2019-02-01 Impact factor: 14.676